Reviva Financial Statements From 2010 to 2025

RVPHW Stock  USD 0.13  0.02  13.33%   
Reviva Pharmaceuticals financial statements provide useful quarterly and yearly information to potential Reviva Pharmaceuticals Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Reviva Pharmaceuticals financial statements helps investors assess Reviva Pharmaceuticals' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Reviva Pharmaceuticals' valuation are summarized below:
Market Capitalization
85.8 M
There are over ninety-six available trending fundamental ratios for Reviva Pharmaceuticals, which can be analyzed over time and compared to other ratios. All traders should should check out Reviva Pharmaceuticals' recent fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Market Cap is likely to climb to about 115.8 M in 2025. Enterprise Value is likely to climb to about 93.7 M in 2025
Check Reviva Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Reviva Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 10 K, Net Interest Income of 602.5 K or Interest Income of 602.5 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 20.25. Reviva financial statements analysis is a perfect complement when working with Reviva Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Reviva Pharmaceuticals Correlation against competitors.

Reviva Pharmaceuticals Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets18.2 M27.3 MM
Slightly volatile
Short and Long Term Debt TotalM3.4 M3.7 M
Slightly volatile
Total Current Liabilities20.7 M19.8 M8.5 M
Slightly volatile
Property Plant And Equipment Net2.2 K3.8 K1.6 K
Slightly volatile
Current Deferred Revenue2.2 M2.5 M2.7 M
Slightly volatile
Accounts Payable4.6 M4.4 M1.3 M
Slightly volatile
Cash17.7 M26.9 M7.8 M
Slightly volatile
Non Currrent Assets Other1.5 K1.6 K1.8 K
Slightly volatile
Cash And Short Term Investments17.7 M26.9 M7.8 M
Slightly volatile
Common Stock Total Equity8481.1 K736
Slightly volatile
Common Stock Shares Outstanding14.1 M27.4 M8.1 M
Slightly volatile
Short Term Investments52.2 M58.7 M64 M
Slightly volatile
Liabilities And Stockholders Equity18.2 M27.3 MM
Slightly volatile
Non Current Liabilities Total1.4 M726 K2.9 M
Slightly volatile
Other Stockholder Equity105.2 M161.1 M87.7 M
Slightly volatile
Total Liabilities21.7 M20.7 M8.7 M
Slightly volatile
Property Plant And Equipment Gross50.4 K48 K16.9 K
Slightly volatile
Short and Long Term DebtM3.4 M3.7 M
Slightly volatile
Total Current Assets18.2 M27.3 MM
Slightly volatile
Capital Stock2.4 K2.5 K18.2 M
Slightly volatile
Short Term DebtM3.4 M3.7 M
Slightly volatile
Common Stock1.7 K3.2 K1.1 K
Slightly volatile
Other Assets778 K464.4 K236.6 K
Slightly volatile
Other Current Assets504.5 K299.6 K251.4 K
Slightly volatile

Reviva Pharmaceuticals Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision10 K19.5 K5.1 K
Slightly volatile
Interest Income602.5 K573.8 K134.3 K
Slightly volatile
Depreciation And Amortization212.7 K223.9 K158.2 K
Slightly volatile
Interest Expense156.3 K164.5 K427.2 K
Slightly volatile
Selling General Administrative9.8 T9.3 T1.7 T
Slightly volatile
Other Operating Expenses47.7 M45.4 M10.8 M
Slightly volatile
Research Development37.9 T36.1 T6.6 T
Slightly volatile
Total Operating Expenses47.7 T45.4 T8.3 T
Slightly volatile
Reconciled Depreciation91.4996.3472
Slightly volatile
Cost Of Revenue579.8 K652.3 K711.2 K
Slightly volatile

Reviva Pharmaceuticals Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow12.6 M21.3 M5.8 M
Slightly volatile
Other Cashflows From Financing ActivitiesM5.1 M1.7 M
Slightly volatile
Depreciation91.4996.3472
Slightly volatile
Total Cash From Financing Activities40.1 M38.1 M10.3 M
Slightly volatile
End Period Cash Flow17.7 M26.9 M7.8 M
Slightly volatile
Issuance Of Capital Stock18.5 M31.6 M7.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables3.5 M3.3 MM
Slightly volatile
Payables Turnover0.580.650.706
Slightly volatile
Cash Per Share1.071.1315.2798
Slightly volatile
Days Payables Outstanding406457498
Slightly volatile
Income Quality0.620.650.6877
Pretty Stable
Current Ratio1.511.591.7237
Slightly volatile
Graham Number2.8 K2.7 K535
Slightly volatile
Graham Net Net0.250.2613.53
Slightly volatile
Interest Debt Per Share0.01020.01080.9874
Slightly volatile
Debt To Assets1.2 K1.3 K1.4 K
Slightly volatile
Days Of Payables Outstanding406457498
Slightly volatile
Ebt Per Ebit0.00.01.1947
Slightly volatile
Quick Ratio1.511.591.7237
Slightly volatile
Net Income Per E B T945.4 K900.4 K177.9 K
Slightly volatile
Cash Ratio1.491.561.6695
Slightly volatile
Debt Ratio1.2 K1.3 K1.4 K
Slightly volatile

Reviva Pharmaceuticals Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap115.8 M110.3 M49.6 M
Slightly volatile
Enterprise Value93.7 M89.3 M44.2 M
Slightly volatile

Reviva Fundamental Market Drivers

Cash And Short Term Investments23.4 M

About Reviva Pharmaceuticals Financial Statements

Reviva Pharmaceuticals investors use historical fundamental indicators, such as Reviva Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Reviva Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue2.5 M2.2 M
Cost Of Revenue652.3 K579.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Reviva Stock Analysis

When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.